NCT04249778 Dapagliflozin at Discharge on Hospital Heart Failure Readmission Status COMPLETED Phase PHASE4
NCT04234867 Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) Status TERMINATED Phase PHASE1
NCT04215523 Replication of the DECLARE Diabetes Trial in Healthcare Claims Status COMPLETED Phase N/A
NCT04149067 Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in Spain Status COMPLETED Phase N/A
NCT04014192 Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE4
NCT03982238 Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients Status COMPLETED Phase PHASE4
NCT03961659 Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy. Status UNKNOWN Phase NA
NCT03877237 DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction Status COMPLETED Phase PHASE3
NCT03877224 DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction Status COMPLETED Phase PHASE3
NCT03871621 Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial Status COMPLETED Phase PHASE4
NCT03782259 Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2 Status COMPLETED Phase PHASE4
NCT03762850 A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03710460 Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity Status UNKNOWN Phase PHASE4